Canadian approval for Baxter's heart assist device:
This article was originally published in Clinica
Executive Summary
Baxter International has received approval to market its Novacor left ventricular assist system in Canada. The implantable, electric device is designed to support circulation in patients with heart failure, allowing them to live in their own homes while awaiting a suitable heart donor. It is CE-marked and was approved by the US FDA last September.